148 related articles for article (PubMed ID: 9591046)
1. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
Sikora J; Dworacki G; Zeromski J
Lung; 1996; 174(5):303-13. PubMed ID: 8843056
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of immunophenotype of lymphoid cells isolated from malignant pleural effusions.
Jezewska E; Sikora J; Słowik-Gabryelska A; Zeromski J
Arch Immunol Ther Exp (Warsz); 1993; 41(1):51-6. PubMed ID: 8239908
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Nat Immun; 1998; 16(5-6):244-55. PubMed ID: 11061592
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease.
Budna J; Spychalski Ł; Kaczmarek M; Frydrychowicz M; Goździk-Spychalska J; Batura-Gabryel H; Sikora J
Immunobiology; 2017 Mar; 222(3):499-505. PubMed ID: 27773662
[TBL] [Abstract][Full Text] [Related]
7. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
Strauss G; Gückel B; Wallwiener D; Moldenhauer G
Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
[TBL] [Abstract][Full Text] [Related]
8. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2.
Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T
Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227
[TBL] [Abstract][Full Text] [Related]
9. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.
Onishi H; Morisaki T; Kuga H; Katano M; Doi F; Uchiyama A; Sugitani A; Wada J; Chijiiwa K; Tanaka M
Immunol Invest; 2002 May; 31(2):121-35. PubMed ID: 12148948
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
[TBL] [Abstract][Full Text] [Related]
11. Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization.
Aguiar LM; Antonangelo L; Vargas FS; Zerbini MC; Sales MM; Uip DE; Saldiva PH
Clinics (Sao Paulo); 2008 Oct; 63(5):637-44. PubMed ID: 18925324
[TBL] [Abstract][Full Text] [Related]
12. Analysis of pleural effusions using flow cytometry.
Ceyhan BB; Demiralp E; Celikel T
Respiration; 1996; 63(1):17-24. PubMed ID: 8833988
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
DeLong P; Carroll RG; Henry AC; Tanaka T; Ahmad S; Leibowitz MS; Sterman DH; June CH; Albelda SM; Vonderheide RH
Cancer Biol Ther; 2005 Mar; 4(3):342-6. PubMed ID: 15846066
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB; Gheith SM
Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
Kaern J; Tropé CG; Kristensen GB; Pettersen EO
Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders].
Klimiuk J; Domagała-Kulawik J; Krenke R; Chazan R
Pol Arch Med Wewn; 2004 Mar; 111(3):291-6. PubMed ID: 15230209
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
[TBL] [Abstract][Full Text] [Related]
19. Expression of TCR-zeta chain and apoptosis in subpopulations of tumor-associated lymphocytes (TALs) from malignant pleural effusions.
Sikora J; Zeromski J
Folia Histochem Cytobiol; 2002; 40(4):347-51. PubMed ID: 12502185
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells with a potent accessory activity are present in human exudative malignant pleural effusions.
Gjomarkaj M; Pace E; Melis M; Spatafora M; D'Amico D; Toews GB
Eur Respir J; 1997 Mar; 10(3):592-7. PubMed ID: 9072990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
